Bright Minds Biosciences announced the successful completion of its three-part Phase 1 study of BMB-101 The post Bright Minds Biosciences Announces Positive...
Source: Patrick Trucchio 07/19/2023 The firm continues advancing its lead drug candidates, including those for anxiety and treatment-resistant...
Filament Health Corp. (OTCQB: FLHLF / NEO: FH / FSE: 7QS), a clinical‐stage natural psychedelic drug development company, and Jupiter Acquisition...
The agreement would merge Filament with Jupiter Acquisition Corporation (NASDAQ: JAQC) The post Filament Health Heading to NASDAQ With SPAC Merger appeared...
Filament Health (NEO: FH) is claiming that shareholders are about to receive US$0.85 per share in value following an agreement The post Filament Health...
It is unclear whether Lightburn will transition as the head honcho of the new entity. The post Psychedelic Drug Developer Set for Nasdaq Listing in $210...
FSD Pharma successfully countered a $4 million claim, but still had to cough up nearly half of that. The post FSD Pharma Wins Multi-Million Dollar Dispute...
The ASX is down 0.5% at lunchtime, Indiana Resources gets compo from Tanzania and Janet Yellen got into the mushies ... Read More The post ASX...
Tel Aviv, Israel / Vancouver, Canada, July 17, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc.... The post Clearmind Medicine Announces Share-Based...
Results of COMPASS Pathways’ study suggests that SSRIs do not interfere with the potential therapeutic effect of COMP360 The post Positive Data From...